Status:

COMPLETED

Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes

Lead Sponsor:

Johns Hopkins Bloomberg School of Public Health

Collaborating Sponsors:

International Centre for Diarrhoeal Disease Research, Bangladesh

United States Agency for International Development (USAID)

Conditions:

Anemia

Diarrhea

Eligibility:

All Genders

6-18 years

Phase:

PHASE4

Brief Summary

With the long-term public health goal of developing an effective micronutrient supplementation program to improve child health by improving iron and zinc status and decreasing morbidity due to diarrhe...

Detailed Description

Iron supplementation is used in reducing anemia and improving hemoglobin status. Zinc supplementation is emerging as possibly an efficacious preventive measure in decreasing incidence of severe diarrh...

Eligibility Criteria

Inclusion

  • Children 6-18 months old
  • Permanent residents of the selected villages

Exclusion

  • Severe malnutrition requiring hospitalization (defined as weight for height \<-3 SD Z-score)
  • Severe anemia requiring treatment (hemoglobin \< 70 g/L)
  • Chronic illness that would impair feeding ability
  • Likely to move in next 6 months.
  • Fever greater than 38.5
  • Regular iron supplementation

Key Trial Info

Start Date :

May 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2008

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT00470158

Start Date

May 1 2007

End Date

February 1 2008

Last Update

April 20 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

ICDDR,B

Dhaka, Mohakhali, Bangladesh, 1212